Sector: Health Care.Industry: Biotechnology
Seneca Biopharma Inc is a clinical-stage biopharmaceutical company developing novel treatments for diseases of unmet medical need. Its pipeline includes biologics for immunological diseases.
Earnings
see more| Q1 2021 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2021-05-14 | ||||||
| REV | |||||||
| Q4 2020 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2021-03-26 | ||||||
| REV | |||||||
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| SNCA | Seneca Biopharma | -6.67% | 24.2M |
Seneca Biopharma Company Questions & Answers
Q
How do I buy Seneca Biopharma (SNCA) stock?
A
You can purchase shares of Seneca Biopharma (NASDAQ: SNCA) through any online brokerage.
Q
Who are Seneca Biopharma's (SNCA) main competitors?
A
Other companies in Seneca Biopharma’s space includes: Immuron (NASDAQ:IMRN), Anchiano Therapeutics (NASDAQ:ANCN) and Histogen (NASDAQ:HSTO).
Q
What is the target price for Seneca Biopharma?
A
There is no analysis for Seneca Biopharma
Q
How much is Seneca Biopharma (SNCA) stock ?
A
The stock price for Seneca Biopharma (NASDAQ: SNCA) is $1.4 last updated Thu Feb 25 2021 21:00:02 GMT+0000 (Coordinated Universal Time).
Q
When is the next Seneca Biopharma (SNCA) dividend?
A
There are no upcoming dividends for Seneca Biopharma.
Q
When is Seneca Biopharma (NASDAQ:SNCA) reporting earnings?
A
Seneca Biopharma’s Q1 earnings are confirmed from now on May 14, 2021.
Q
When is the upcoming split for SNCA?
A
There is no upcoming split for Seneca Biopharma.